Home Peptide library I Love Sema · Reference notebook
Peptide library A name to look up. A source to follow. One clearer question to take with you.
A note before you browse ↓ Checked 2026-10-30
A dated reading companion Read the policy notebook alongside this index. The existing references keep their earlier evidence and source dates.
Policy context added October 30, 2026.
Read the policy notebook The reference index 11 entries shown
Semaglutide Also listed as: Wegovy
Product status Approved product
Evidence label Randomized evidence Open reference ↗ Tirzepatide Also listed as: Zepbound
Product status Approved product
Evidence label Randomized evidence Open reference ↗ Liraglutide Also listed as: Saxenda
Product status Approved product
Evidence label Randomized evidence Open reference ↗ Dulaglutide Also listed as: Trulicity
Product status Approved product
Evidence label Randomized evidence Open reference ↗ Retatrutide Also listed as: LY3437943
Product status Investigational
Evidence label Randomized evidence Open reference ↗ Cagrilintide
Product status Investigational
Evidence label Randomized evidence Open reference ↗ Tesamorelin Also listed as: Egrifta WR
Product status Approved product
Evidence label Randomized evidence Open reference ↗ Bremelanotide Also listed as: Vyleesi
Product status Approved product
Evidence label Randomized evidence Open reference ↗ Copper tripeptide-1 Also listed as: GHK-Cu
Product status Topical cosmetic
Evidence label Cosmetic-use evidence Open reference ↗ BPC-157
Product status Not FDA-approved
Evidence label Early human evidence Open reference ↗ Ipamorelin Also listed as: Ipamorelin acetate
Product status Not FDA-approved
Evidence label Randomized evidence Open reference ↗ Keep a question beside the record
Take the next step in your reading. Open an entry for its reference fields, dated source list, and a short reading note. The questions are prompts for examining a claim, not instructions to choose a treatment.
This library is educational reading, not personal medical advice. These pages have not completed clinician medical review.